Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) Short Interest Down 6.3% in November
Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX – Get Free Report) saw a large decline in short interest in November. As of November 15th, there was short interest totalling 6,500,000 shares, a decline of 6.3% from the October 31st total of 6,940,000 shares. Based on an average daily trading volume, of 713,900 shares, the days-to-cover ratio is presently […]
More Stories
Omnicom Group Inc. (NYSE:OMC) Shares Sold by Redwood Investment Management LLC
Redwood Investment Management LLC trimmed its holdings in shares of Omnicom Group Inc. (NYSE:OMC – Free Report) by 5.7% during...
Erste Asset Management GmbH Invests $104,000 in Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT)
Erste Asset Management GmbH purchased a new position in Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT – Free Report) during the third quarter,...
Atom Investors LP Takes $244,000 Position in Paramount Global (NASDAQ:PARAA)
Atom Investors LP bought a new stake in Paramount Global (NASDAQ:PARAA – Free Report) during the 3rd quarter, according to...
Insider Selling: MoneyLion Inc. (NYSE:ML) CEO Sells 16,080 Shares of Stock
MoneyLion Inc. (NYSE:ML – Get Free Report) CEO Diwakar Choubey sold 16,080 shares of the business’s stock in a transaction...
Parsons Co. (NYSE:PSN) Shares Purchased by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its position in shares of Parsons Co....
Atom Investors LP Acquires New Holdings in BlackLine, Inc. (NASDAQ:BL)
Atom Investors LP purchased a new stake in BlackLine, Inc. (NASDAQ:BL – Free Report) in the 3rd quarter, Holdings Channel.com...